Skip to main content
Industry News
Poll: Some hospitals experiencing remdesivir shortages

A poll conducted by the American Society of Health-System Pharmacists showed that 33% of 131 respondents reported that their supply of remdesivir was insufficient to treat all patients with COVID-19 infections eligible for the drug. The survey also found that 16% said they still had supplies of dexamethasone but these were only sufficient for less than seven days.

Full Story: